REGENERON PHARMACEUTICALS, INC.: summary
REGENERON PHARMACEUTICALS, INC. reported 3 positions with a reported value of $179.63M in its 13F for Q3 2026. Compared with Q2 2026: 0 new positions, 0 exited.
REGENERON PHARMACEUTICALS, INC. reported 3 positions with a reported value of $179.63M in its 13F for Q3 2026. Compared with Q2 2026: 0 new positions, 0 exited.